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Obesity is an increasingly prevalent and severe health concern with a substantial heritable component and marked sex diﬀerences.
We sought to determine if the eﬀect of genetic variants also diﬀered by sex by performing a genome-wide association study
modeling the eﬀect of genotype-by-sex interaction on obesity phenotypes. Genotype data from individuals in the Framingham
Heart Study Oﬀspring cohort were analyzed across ﬁve exams. Although no variants showed genome-wide signiﬁcant gene-by-sex
interaction in any individual exam, four polymorphisms displayed a consistent BMI association (P-values .00186 to .00010) across
all ﬁve exams. These variants were clustered downstream of LYPLAL1, which encodes a lipase/esterase expressed in adipose tissue,
a locus previously identiﬁed as having sex-speciﬁc eﬀects on central obesity. Primary eﬀects in males were in the opposite direction
from females and were replicated in Framingham Generation 3. Our data support a sex-inﬂuenced association between genetic
variation at the LYPLAL1 locus and obesity-related traits.
1.Introduction
Overweight and obesity present a major public health
challenge in the developed world and are a primary focus of
preventive healthcare. Rates of both overall adiposity, mea-
sured by body mass index (BMI), as well as central (intra-
abdominal) adiposity, measured by waist circumference
(WC) or waist to hip ratio (WHR) have been steadily rising
during the past several decades, accompanied by increased
rates of diabetes mellitus, cardiovascular disease, and other
morbidities [1]. In the United States, regional, racial, and
sex diﬀerences in adiposity have been noted, but the patterns
are complex and changing over time [1]. According to U.S.
national health survey data, men on average have had a
higherBMIthanwomen,butsincethemid1990stheaverage
BMI in women has been higher than men [2]. Men also
tend to have larger abdominal girth than women, and this
disparity has persisted over time [3, 4].
Obesity is a heritable trait and recent genome-wide
association studies have identiﬁed dozens of loci inﬂuencing
measures of adiposity [5–8]. Sex diﬀerences in the heritabil-
ity of obesity-related traits have been noted as well in several
studies [9]. In addition, linkage analysis in both rodent
models and humans have found evidence of sex-speciﬁc
loci aﬀecting obesity-related traits [10, 11]. Framingham
HeartStudyinvestigatorsfoundwidespreadevidenceforsex-
speciﬁceﬀectsofgeneticlocionbodymassindex,identifying
several chromosomal regions with suggestive linkage to BMI
in one sex, but not the other [11]. Indeed some eﬀects were
only seen in sex-stratiﬁed analysesand were not at all evident
i nt h ec o m b i n e dc o h o r to fm e na n dw o m e n .M o r er e c e n t l y ,
two genome-wide association study meta-analyses of WHR
examined their top loci for sex diﬀerences and identiﬁed sex-
speciﬁc eﬀects for several loci [8, 12].
We sought evidence for signiﬁcant diﬀerences in SNP
eﬀects on adiposity traits in men and women across the2 Journal of Obesity
genome by carrying out a genome-wide association study
modeling gene by sex interaction for WHR, WC, and BMI
in the population-based Framingham Heart Study. Genome-
wide association analysis of SNPs having main eﬀects (as
opposed to gene by sex interaction) on obesity were reported
earlier in the Framingham Heart Study using 100K SNPs,
but gene by sex interactions were not considered at that
time [13]. Subsequently, the full genotype data (>500K
SNPs) have been pooled with other studies and reported in
large meta-analyses, which found evidence of gene by sex
interaction for WHR but not BMI among the SNPs with
main eﬀects [5, 8].
2.MaterialsandMethods
2.1. Study Population. We conducted this research using data
from the Framingham Heart Study, a population-based, lon-
gitudinalstudyoffamilieslivinginthetownofFramingham,
Massachusetts collected over three-generations beginning in
1948. An overview of the study is provided at the dbGap
website (http://www.ncbi.nlm.nih.gov/sites/entrez?db=gap)
and detailed descriptions are available elsewhere [14, 15].
Brieﬂy, the original study (Generation 1) enrolled 5209
individuals, primarily Caucasian, and it later added the
oﬀspring of the original cohort (Generation 2), and the
grandchildren(Generation3)oftheoriginalcohort.Primary
analyses were carried out using data from the ﬁve ﬁrst exams
of subjects in Generation 2, collected between 1971 and
1994. Obesity-related traits evaluated in this study included
BMI, measured at exams 1, 2, 3, 4, and 5, WHR, measured
at exams 4 and 5, and WC measured at exams 4 and 5.
We limited our analyses to these exams due to a drop in
sample size at subsequent exams. Replication of genome
wideassociationstudy(GWAS)resultswassoughtinsubjects
from Generation 3 (data collected in 2002–2005).
Individualswithdiabetes(n = 92,94,59,27,116,and136
for generation 2 exams 1, 2, 3, 4, 5 and generation 3 exam
1, resp.) or thyroid disorder (n = 117,94,9,36,265, and 72
for generation 2 exams 1, 2, 3, 4, 5 and generation 3 exam
1, resp.) were removed because these diseases have an eﬀect
on both BMI and fat distribution. The data were further
trimmed, excluding individuals with outlier trait values
determined by taking the mean of the phenotype (indepen-
dently for each exam and each sex) and adding/subtracting
three standard deviations. Removal of outlier values in
the BMI GWAS data was performed with weight, height,
and BMI. WC and hip circumference (HC) outliers were
also eliminated in the waist phenotype GWAS. Finally,
we restricted our analysis to premenopausal women and
individuals under the age of 50 to enhance diﬀerences related
to estrogen-mediated gene by sex interaction and to reduce
as much as possible the age-related diﬀerences in association
that may occur across exams. The total sample sizes for the
BMI GWAS after genotype quality control and trait outlier
removal were 3150, 1991, 1630, 1330, 990, and 2872 for
generation 2 exams 1, 2, 3, 4, 5, and generation 3 exam 1,
respectively. The sample sizes for the waist phenotype GWAS
were 1330, 984, and 2872 for generation 2 exams 4, 5 and
generation 3 exam 1, respectively.
2.2. Genotype Data and Quality Control. Genome-wide
genotypes and detailed clinical data have been made acces-
sible to the research community through the SHARe project
(SNP-Health Association Resource). The study protocol was
approved by Duke University’s Institutional Review Board
and the Framingham SHARe Data Access Committee. The
unﬁltered genotype data contained 9215 individuals (all
generations) genotyped for 549782 SNPs. This included
500568 SNPs from the Aﬀymetrix 500K mapping array and
49214 SNPs from the Aﬀymetrix 50K supplemental array
(Aﬀymetrix, Santa Clara, CA, USA). We used the toolset
PLINK [16] to perform quality control. Individuals were
excluded if genotyping rates were less than 97%. Markers
were excluded if genotyping rates were less than 97%,
minor allele frequencies were less than 0.05, or if Hardy-
Weinberg P-values were less than .001. All SNP exclusions
were made sequentially in the preceding order. Using this
ﬁltered data, we checked for Mendel errors using a 5% cutoﬀ
per family, and a 10% cutoﬀ per SNP (as deﬁned in PLINK),
but none were detected. Individuals were also excluded if
the predicted sex based on X-chromosome genotypes did
not match the recorded sex. Pairwise identity-by-descent
measures were calculated to detect replicated samples and
unknown interfamilial relationships. We detected 4 identical
twins and randomly selected one member of each pair for
the analytic sample. After quality controls, the remaining
sampleconsistedofgenotypedataon360811SNPs,attaining
a genotyping rate of 99.5%.
2.3. Statistical Analyses. Analysis of WHR and WC were
based on data obtained at exam 4 (n = 1330) and exam
5( n = 984) of subjects from Generation 2. The gene by
sex GWAS was run on data from each exam separately. We
ran the full model for both WHR and WC regressed on
BMI, age, age-squared, genotype, sex, and the genotype-
by-sex cross product. BMI was available at all exams, with
adequate sample sizes on the ﬁrst ﬁve exams. Five separate
GWAS were run using the full model of BMI regressed
on age, age-squared, genotype, sex, and the genotype-by-
sex cross product—one each for exams 1, 2, 3, 4, and
5 of Generation 2. SNPs were evaluated for associations
in an additive genetic model. A main eﬀect GWAS was
also run for BMI across the ﬁve exams, using the model
speciﬁcations above without the cross product term. Sex-
speciﬁc associations were tested using the full model of BMI
regressed on age, age-squared, and genotype on each sex.
To account for relatedness, we used generalized estimating
equations while accounting for sibling correlation in the
Yags package [17]o ft h eR statistical language. The P-
values of the covariates were obtained via the Wald test
using robust standard errors. The Framingham population
has been studied extensively, and evidence for considerable
population stratiﬁcation has not been detected. To test this
assumption, we estimated the inﬂation factor by dividing
the median of the observed χ2 statistics for each GWAS, by
the expected median in the absence of stratiﬁcation (0.456)
[18, 19]. Also, adjusted for population stratiﬁcation with the
scores of the ﬁrst 10 principal components, computed with
Eigenstrat [20]. We deﬁned genome-wide signiﬁcance usingJournal of Obesity 3
a Bonferroni cutoﬀ of 1.4 × 10
−7, which corrects for 360811
tests.
Following genome-wide analysis, we annotated results
using the WGAViewer package [21], Ensembl [22], and the
UCSC genome browser. We generated plots using the Gap
package [23] of the R statistical language and Haploview
software [24].
To enrich for true positive associations, we took a
strategy whereby associations that appeared in all exams
were considered to have a higher likelihood of being true
associations.Weexpectedearlierexamstohavegreaterpower
due to larger sample sizes, but other factors, including
decreased heritability with age [11]m a ya ﬀect the results as
w e l l .T h i ss t r a t e g yr e q u i r e du st om a k es o m ed e c i s i o n sa b o u t
what cutoﬀ to use when comparing results across exams. We
took the consensus across exams of the top most signiﬁcant
10,100,1000,and10000hitsandfound0,0,4,and105SNPs,
respectively, and focused on the four SNPs from the top 1000
consensus further.
3. Results
Characteristics of the subjects from Generations 2 and 3
of the Framingham Study used in the current analyses are
presented in Table 1, broken down by exam. For each exam,
we restricted our analyses to men and women <50 years of
age, resulting in a decrease in sample size over time, above
and beyond the loss due to death or nonparticipation.
3.1. Genome-Wide Association Analysis of Gene by Sex Inter-
action for WHR and WC and BMI. None of the gene-by-
sex interaction GWAS revealed genome-wide signiﬁcant loci.
ForBMIwenotedmarkedheterogeneityinquantile-quantile
(QQ)plotsbetweenexams(Figure 1),whichdoesnotappear
to be a function of sample size (which decreases with exam).
There is also some evidence of inﬂation in the QQ plots,
which was not alleviated after controlling for population
stratiﬁcation.Insex-stratiﬁedanalysis,theinﬂationappeared
to be restricted to men. The top 1000 hits from each exam
for each trait (ordered by the P-value of the gene by sex
interaction term) were extracted (Supplementary Tables S1,
S2, and S3 available online on doi:10.1155/2011/329038),
and the intersection of those datasets was sought for each
trait.
For WHR, we identiﬁed 43 SNPs (28 unique loci) and for
WC,weidentiﬁed43SNPs(27uniqueloci)appearingamong
the top 1000 in both exams 4 and 5 (Tables S2 and S3). When
examining loci across these two traits, SNPs near SPOCK3,
OSTF1, RAB31,a n dRPF1 appear in the top 1000 consensus
for WC and WHR. SPOCK3 stands out as appearing among
the top 100hits across both exams 4 and 5 for WC (P =
5.33×10
−7 and P = 2.45×10
−5) and WHR (P = 1.85×10
−4
and P = 7.95 ×10
−5).
For BMI, only four SNPs appeared among the top
1000hitsinallﬁveexams.AllfourSNPslocalizedtothesame
linkage disequilibrium block on chromosome 1, ∼100kb
downstream of LYPLAL1. Supplementary Table S3.6 shows
the location, minor allele frequency, P values, and rank of
eachSNPbysexinteractionbyexam.Weweremostintrigued
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Figure 1: QQ plots for gene by sex interaction (a) and main eﬀect
(b) GWAS for body mass index (BMI) in Generation 2, exams 1, 2,
3, 4, and 5.
by these ﬁndings as the LYPLAL1 locus has been reported as
a sex-speciﬁc locus aﬀecting central adiposity in two prior
genome-wide association meta-analyses [8, 12]. The extent
of linkage disequilibrium (LD) surrounding the associated
SNPs in the region of LYPLAL1 was determined in the Hap
Map phase 3CEU population by identifying the farthest
SNP away in each direction that had r2 > 0.5f o re a c h
of the four SNPs. The LD block extends over 330kb from
position 217,321,833 to 217,655,426, and encompasses the
LYPLAL1 gene (Figure 2). The block does not include the
SNPs fromLindgren et al.[12] orHeid et al. [8],whicharein
moderatelinkagedisequilibriumwitheachotherandlocated
an additional 55kb and 258kb downstream of LYPLAL1,
respectively.
3.2. Replication of LYPLAL1 SNP Association with BMI in
Framingham Generation 3 Subjects. We next sought to repli-
cate the observed association in subjects from Generation 3
of the Framingham Study. Again, we restricted our analyses
to those less than 50 years of age. A comparison of results by
sex in the ﬁve exams of Generation 2 and in Generation 3
are shown in Figure 3 for the top associated LYPLAL1 SNP.
The SNP by sex interaction for LYPLAL1 was signiﬁcant in
all Generation 2 exams, but not signiﬁcant in Generation
3 subjects. However, when stratiﬁed by sex, the minor
allele showed a consistent increase in BMI in men across
generations (Figure 3). In contrast, in women the minor4 Journal of Obesity
Table 1: Mean ± standard deviation for obesity-related traits in Framingham subjects <50 years old.
Population Generation 2,
exam 1
Generation 2,
exam 2
Generation 2,
exam 3
Generation 2,
exam 4
Generation 2,
exam 5
Generation 3,
exam 1
Sample
size (N)
All 3150 1991 1630 1330 990 2872
Men 1478 958 776 640 463 1388
Women 1672 1033 854 690 527 1484
Age
(years)
All 33.71 ±8.59 38.39 ±6.70 40.46 ±5.77 42.27 ±5.11 43.68 ±4.44 37.63 ±7.27
Men 33.81 ±8.63 38.38 ±6.88 40.47 ±5.92 42.14 ±5.23 43.56 ±4.65 37.79 ±7.30
Women 33.62 ±8.56 38.39 ±6.54 40.45 ±5.63 42.40 ±5.00 43.78 ±4.24 37.47 ±7.24
BMIa
(kg/m2)
All 24.85 ±3.77∗∗∗ 25.10 ±3.79∗∗∗∗ 25.40 ±4.08∗∗∗ 25.97 ±4.37∗ 26.42 ±4.48 26.23 ±4.70
Men 26.42 ±3.47∗ 26.57 ±3.44∗∗ 26.72 ±3.49∗∗ 27.23 ±3.62 27.55 ±3.92 27.42 ±4.03
Women 23.48 ±3.47∗∗∗ 23.74 ±3.59∗∗∗ 24.20 ±4.20∗∗ 24.80 ±4.66∗ 25.42 ±4.70 25.11 ±4.99
Height
(cm)
All 167.62 ±9.36∗∗∗∗ 168.59 ±9.57∗∗∗ 169.66 ±9.20∗ 169.67 ±9.12∗ 169.56 ±9.06 170.91 ±9.18
Men 174.95 ±6.79∗∗∗∗ 175.99 ±6.77∗∗∗ 176.75 ±6.66∗ 176.65 ±6.52∗ 176.69 ±6.41 177.88 ±6.41
Women 161.15±5.90∗∗∗∗∗ 161.73±6.02∗∗∗∗ 163.23 ±5.86∗ 163.20 ±5.81 163.29 ±5.85 164.39 ±6.06
Weight
(kg)
All 69.77 ±14.52∗∗∗∗ 71.25±14.62∗∗∗∗ 72.89 ±14.97∗∗∗ 74.50 ±15.55∗∗ 75.72 ±15.79 76.32 ±16.55
Men 80.26 ±11.76∗∗∗∗ 81.63 ±11.34∗∗∗ 82.78 ±11.82∗∗∗ 84.27 ±12.24∗∗ 85.34 ±13.02 86.06 ±13.76
Women 60.50 ±9.58∗∗∗∗ 61.63±10.01∗∗∗∗ 63.90 ±11.45∗∗∗ 65.45 ±12.51∗ 67.27 ±12.91 67.20 ±13.47
WCb (cm)
All — — — 86.70 ± 13.92∗∗∗∗ 88.95 ±13.30∗∗∗ 91.03 ±13.33
Men — — — 95.85 ±9.93∗∗ 96.49 ±10.34 96.50 ±11.15
Women — — — 78.21±11.50∗∗∗∗∗ 82.36 ±12.04∗∗∗ 85.90 ±13.18
HCc (cm)
All — — — 100.07 ±9.08 101.37 ±8.63 —
Men — — — 101.31 ±7.18 101.83 ±6.85 —
Women — — — 98.92 ± 10.42 100.98 ±9.93 —
WHRd
All — — — 0.86 ± 0.10 0.88 ±0.09 —
Men — — — 0.95 ± 0.06 0.95 ±0.06 —
Women — — — 0.79 ± 0.06 0.81 ±0.07 —
aBody mass index,
bWaist circumference,
cHip circumference,
dWaist to hip ratio,
∗Signiﬁcant diﬀerence between Generation 2 and Generation 3 after controlling for age and age-squared (∗P<. 001, ∗∗P<1e−5, ∗∗∗P<1e−10, ∗∗∗∗P<
1e −20, ∗∗∗∗∗P<1e −50). Signiﬁcance in age diﬀerences is not noted.
allele was associated with lower BMI in Generation 2 but not
in Generation 3.
3.3. Association of LYPLAL1 SNPs with Obesity-Related Traits.
To understand the relationship between LYPLAL1 SNPs and
obesity in greater detail, we examined the top SNP from the
present study (rs7552206) along with SNPs from the Lind-
grenetal.[12] and Heid et al. [8] studies for association with
related phenotypes, including height, weight, WC, and WHR
(Supplemental Table S4). The rs7552206 by sex interaction
f o rB M It r a c k e dw i t hw e i g h ti na l lﬁ v ee x a m s ,a n dw i t h
WC and HC in the two exams that had these data available.
However, the waist and hip associations were completely or
nearly completely attenuated when controlling for BMI. For
rs2605100 (Lindgren et al. [12]), no compelling evidence
of gene by sex interaction in central adiposity was found.
Heid et al. [8] independently found a female-biased WHR
association with LYPLAL1 (rs4846567), an SNP in moderate
linkage disequilibrium with the Lindgren et al. SNP. We
analyzed an available proxy for this SNP (rs2820446, Hap
Map CEU r2 = 1) and found a borderline signiﬁcant gene-
by-sex interaction with WHR (P = .09; Supplement S4).
3.4. Genome-Wide Association Analysis of Gene Main Eﬀects
for BMI. We also explored our cross-exam consensus
approachfordetectingsigniﬁcantmaineﬀectsforBMI,using
thesameage-restricteddatasetsasthegenebysexinteraction
analyses. As with our gene by sex interaction analyses,
the QQ plots show marked heterogeneity between exams
(Figure 1)andmodestinﬂation,whichwasnotaccountedfor
by population stratiﬁcation. Only one SNP, located ∼26kb
upstream of DUSP10 on chromosome 1, appeared among
the top 1000hits (Supplement S5) in all ﬁve exams of
Generation 2 and was borderline signiﬁcant in Generation 3
subjects (Figure 4). Interestingly, this locus is approximately
2.4MbawayfromthegenebysexinteractionLYPLAL1SNPs.
No SNPs from prior genome-wide association studies of
BMI showed up among our top 1000 consensus, including
SNPs in the genes INSIG2, FTO [13, 25], and MC4R
[26]( Figure 4). Surprisingly, the SNPs identiﬁed with theJournal of Obesity 5
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Figure 2: Linkage disequilibrium (shown as r2) in the region encompassing LYPLAL1, the consensus SNPs associated with body mass index
(BMI) in our gene by sex interaction GWAS, and the sex-speciﬁc SNPs associated with waist to hip ratio (WHR) in recent GWAS meta-
analyses.
consensus approach yielded more signiﬁcant P values than
other loci.
4. Discussion
We carried out a genome-wide assessment of gene by sex
interaction for standard measures of obesity in men and
women less than 50 years of age in the Framingham Heart
Study. We took advantage of longitudinal data from multiple
exams to identify loci showing consistent evidence of SNP
by sex interaction across exams. Among the most prominent
was a region ∼100kb downstream of LYPLAL1, encoding the
lysophospholipase-like 1 protein. We found evidence across
ﬁveexams,spanninga20-yeartimeframe,ofoppositeeﬀects
of genetic variants in this region on BMI in men and women.
An attempt to replicate this ﬁnding in a later generation
of Framingham Heart Study subjects found a consistent,
signiﬁcant association in men, but not in women, possibly
indicating a male-speciﬁc association.
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Ours is not the ﬁrst study to link LYPLAL1 to obesity:
two other genome-wide association meta-analyses identiﬁed
this locus as having a sex-speciﬁc eﬀect on WHR [8, 12].
While neither SNP is in linkage disequilibrium with the
region identiﬁed in our study, the coincidental discovery
of two distinct regions near the LYPLAL1 locus associated
with obesity-related traits in a sex-speciﬁc fashion warrants
further attention. Moreover, a prior linkage analysis of BMI
in Generation 2 of the Framingham Heart Study identiﬁed
a male-biased linkage for BMI in the vicinity of LYPLAL1
on chromosome 1q41 [11]. None of the other sex-speciﬁc
obsesity loci from Heid et al. [8] were found in our
study.
LYPLAL1 is a member of the lysophospholipase gene
family (EC number 3.1.1.5). It was initially identiﬁed
as a gene on chromosome 1 found incidentally during
investigation of a familial chromosomal translocation [27].
It was named on the basis of ∼30% predicted amino acid
sequence homology with lysophospholipases I and II [28].
The sequence suggests an α/β hydrolase fold typically found
in many lipases and esterases. LYPLAL1 was subsequently
identiﬁed as one of 23 esterolytic/lipolytic proteins extracted
from mouse adipose tissue. The presence of an active site
serine was determined by activity tagging with a ﬂuorescent
probe of broad speciﬁcity, resembling a single-chain car-
boxylic acid ester. Similar probes modeling triglyceride and
cholesteryl ester did not tag LYPLAL1 [29]. LYPLAL1 protein
has not yet been isolated, however, and its substrate speci-
ﬁcity is unknown. Along with the gene for adipocyte triglyc-
eride lipase and several others related to lipolysis, LYPLAL1
mRNA was expressed more abundantly in abdominal
subcutaneous adipose tissue from obese versus lean humans
[30].
Given the minimal characterization of LYPLAL1,w e
can only speculate about its sex-speciﬁc role in adiposity.
It might be involved in triglyceride synthesis or lipolysis,
similar to some of the proteins with which it is coexpressed
[31]. If indeed it is a lysophospholipase, it might play a
role along with autotaxin, a secreted phospholipase D, in
regulating extracellular levels of lysophosphatidic acid in
adipose tissue. Via speciﬁc G protein-coupled receptors,
lysophosphatidic acid has been shown to have varying eﬀects
on adipocyte diﬀerentiation and growth [32–34]. Another
possibility relates to the endocannabinoid system, which has
been a recent pharmacologic target for investigative obesity
treatments. The monoglyceride, 2-arachidonoyl glycerol, as
well as other esters or amides of long-chain polyunsaturated
fatty acids belong to a family of compounds that are natural
ligands for cannabinoid receptors. These endogenous sig-
naling molecules aﬀect physiologic and behavioral processes
governing appetite and energy metabolism [31].
Interestingly lipolysis control has been shown to vary
b ys e xi ns o m es t u d i e s[ 35] but not others [36]. The
aforementioned study showing support for sex diﬀerences
in lipolysis suggests that women show greater sensitivity
to lipolysis in abdominal subcutaneous fat. The authors
argue that the diﬀerences in lipolysis sensitivity are due to
the presence of fewer inhibitory alpha-adrenergic receptors
in the abdominal subcutaneous adipose tissue. This area
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Figure 4: Signiﬁcance level of main eﬀect (ME) and/or gene by sex
interaction (GxS) associations with body mass index (BMI) and/or
waist to hip ratio (WHR) for various loci of interest.
of lipid metabolism is not well understood, but recent
discoveries and conﬂicting opinions warrant further studies
on LYPLAL1 and its potential roles and sex-speciﬁc eﬀects in
lipid metabolism and obesity.
Our analysis revealed marked heterogeneity of eﬀects
across diﬀerent exams of the study, both in gene by sex
interaction and main eﬀect analyses, even among established
locifromothergenome-wideassociationstudiesofBMI.The
consensus approach appears to be robust, identifying a locus
with strong prior evidence of gene by sex interaction for
obesity-related traits. Using this approach, we also identiﬁed
a possible novel candidate locus for BMI, located ∼26kb
upstream of DUSP10, encoding a dual speciﬁcity protein
phosphatase. The DUSPs are a subclass of the protein
tyrosine phosphatase gene superfamily that controls MAP
kinase function [37].
Our study was carried out in the Framingham Heart
Study Oﬀspring cohort, a longitudinal, population-based
study. Although no loci reached genome-wide signiﬁcance in
gene by sex interaction analyses, the longitudinal nature of
the data allowed us to prioritize SNPs based on consistency
of eﬀect across exams. However, data on waist circumference
were available only at two exams, limiting the eﬀectiveness
of our approach for these traits. Nonetheless, for BMI, this
approach yielded a plausible candidate sex-speciﬁc locus
and another sex-independent locus. Interestingly, in both
of these cases, results from Generation 3 were not as
signiﬁcant as in Generation 2, possibly reﬂecting a cohort
eﬀect: Generation 2 subjects were enrolled nearly a decade or
more prior to Generation 3 subjects. Generation 3 subjects
were on average more overweight than Generation 2 subjects
at comparable ages, consistent with temporal trends of
increasing overweight/obesity observed in other population-
based studies. These diﬀerences, driven in large part by
changes in diet and physical activity over time, may impact
the heritability over time and thus, the ability to detect
genetic eﬀects.Journal of Obesity 7
5. Conclusions
Few studies have systematically modeled gene by sex inter-
action for obesity-related traits on a genome-wide level.
We conﬁrm in our study that SNPs in the vicinity of
LYPLAL1 may exhibit sex-speciﬁc eﬀects on obesity-related
traits. By utilizing a well-designed population-based study,
and taking advantage of longitudinal data, we were able to
demonstratethiseﬀectusingamuchsmallersamplesizethan
the original meta-analysis that identiﬁed this locus. This has
implications for the design of GWAS, where large samples
sizesareoftensoughtsometimesattheexpenseofpopulation
homogeneity. We suggest that smaller epidemiologically
sound population-based studies may be more powerful
than larger heterogeneous metacohorts. We also highlight
the importance of considering longitudinal robustness of
association within a cohort as another means of prioritizing
lociandreducingfalsepositiveassociations.Futurestudiesof
LYPLAL1 are needed to determine the basis of the apparent
sex-speciﬁc eﬀect on obesity.
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